Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

89
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
89
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

108
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
108
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

109
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
What is Gene Expression?01:36

What is Gene Expression?

12.1K
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is comprised  of nucleotides and proteins are comprised of amino acids, a mediator is required to convert the information encoded in DNA into proteins. This mediator is the messenger RNA (mRNA). mRNA copies the blueprint from DNA by a process called transcription. In eukaryotes, transcription occurs in the nucleus by complementary base-pairing with the DNA template. The mRNA is then...
12.1K
What is Gene Expression?01:42

What is Gene Expression?

199.3K
Overview
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
199.3K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxytocin and the neurobiology of attachment.

The Behavioral and brain sciences·2014
Same author

Brain somatic mutations: the dark matter of psychiatric genetics?

Molecular psychiatry·2013
Same author

Innovative solutions to novel drug development in mental health.

Neuroscience and biobehavioral reviews·2013
Same author

Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?

Molecular psychiatry·2012
Same author

A bridge to somewhere.

Translational psychiatry·2012
Same author

Regional changes in brain oxytocin receptors post-partum: time-course and relationship to maternal behaviour.

Journal of neuroendocrinology·2009
Same journal

Exercise-induced brain changes in cannabis use disorder: a longitudinal MRI study of a 12-week supervised HIIT program.

Molecular psychiatry·2026
Same journal

Shared and specific associations of amygdala nuclei volumes with PTSD symptom domains and childhood trauma: An ENIGMA-PGC PTSD mega-analysis.

Molecular psychiatry·2026
Same journal

Cross-ancestry pleiotropic analysis of imaging-derived phenotypes enhances risk stratification of depression.

Molecular psychiatry·2026
Same journal

Shared genetic architecture of schizophrenia and Alzheimer's disease and related dementias implicates 16p11.2 and lifespan brain vulnerability.

Molecular psychiatry·2026
Same journal

The neurodevelopmental spectrum: phenotypic architecture, etiology, predictive utility, and specificity across development.

Molecular psychiatry·2026
Same journal

Towards ecological psychiatry: The herbicide glyphosate disrupts behavior through microbiota-gut-brain axis.

Molecular psychiatry·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Understanding how non-coding genomic polymorphisms affect gene expression.

S E Koester1, T R Insel1

  • 1Division of Neuroscience and Basic Behavioral Science, NIMH, NIH, Bethesda, MD, USA.

Molecular Psychiatry
|January 27, 2016
PubMed
Summary
This summary is machine-generated.

The Genotype-Tissue Expression (GTEx) project provides crucial genomic data and post-mortem tissue samples. Researchers can explore how genetic variations influence gene expression across diverse human tissues.

More Related Videos

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

23.4K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

Related Experiment Videos

Last Updated: Mar 26, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K
An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

23.4K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

Area of Science:

  • Genomics
  • Molecular Biology
  • Human Physiology

Background:

  • The Genotype-Tissue Expression (GTEx) project is a vital resource for understanding human genetics.
  • Post-mortem human tissues are essential for studying gene expression patterns.

Purpose of the Study:

  • To investigate the impact of genomic variation on gene expression.
  • To create a comprehensive resource of human tissue data for the research community.

Main Methods:

  • Collecting and analyzing post-mortem human tissue samples.
  • Examining the relationship between genetic variation and gene expression levels.

Main Results:

  • Genomic variation significantly alters gene expression across various human tissues.
  • A large dataset of gene expression and genomic data has been generated.

Conclusions:

  • The GTEx project serves as a valuable resource for genetic and gene expression research.
  • Understanding genetic variation's role in gene expression is key to advancing human health research.